$261.76
0.32% today
Nasdaq, Apr 01, 06:47 pm CET
ISIN
US45784P1012
Symbol
PODD

Insulet Corporation Stock price

$262.61
-9.66 3.55% 1M
+29.86 12.83% 6M
+1.54 0.59% YTD
+94.51 56.22% 1Y
-3.78 1.42% 3Y
+96.93 58.50% 5Y
+229.26 687.44% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
+3.86 1.49%
ISIN
US45784P1012
Symbol
PODD
Sector

Key metrics

Market capitalization $18.44b
Enterprise Value $18.91b
P/E (TTM) P/E ratio 45.37
EV/FCF (TTM) EV/FCF 61.92
EV/Sales (TTM) EV/Sales 9.13
P/S ratio (TTM) P/S ratio 8.90
P/B ratio (TTM) P/B ratio 15.21
Revenue growth (TTM) Revenue growth 22.07%
Revenue (TTM) Revenue $2.07b
EBIT (operating result TTM) EBIT $308.90m
Free Cash Flow (TTM) Free Cash Flow $305.40m
Cash position $953.40m
EPS (TTM) EPS $5.79
P/E forward 61.24
P/S forward 7.53
EV/Sales forward 7.72
Short interest 5.48%
Show more

Is Insulet Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Insulet Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Insulet Corporation forecast:

21x Buy
81%
5x Hold
19%

Analyst Opinions

26 Analysts have issued a Insulet Corporation forecast:

Buy
81%
Hold
19%

Financial data from Insulet Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,072 2,072
22% 22%
100%
- Direct Costs 612 612
14% 14%
30%
1,460 1,460
26% 26%
70%
- Selling and Administrative Expenses 846 846
28% 28%
41%
- Research and Development Expense 220 220
7% 7%
11%
394 394
35% 35%
19%
- Depreciation and Amortization 85 85
17% 17%
4%
EBIT (Operating Income) EBIT 309 309
40% 40%
15%
Net Profit 418 418
103% 103%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Insulet Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Insulet Corporation Stock News

Neutral
Business Wire
13 days ago
ACTON, Mass.--(BUSINESS WIRE)--Insulet's RADIANT trial demonstrates meaningful glycemic improvements with Omnipod 5 AID following direct transition from multiple daily injections.
Neutral
Business Wire
14 days ago
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has priced a private placement of $450 million aggregate principal amount of senior unsecured notes due 2033 (the “Notes”). The Notes will bear interest at an annual rate of 6.50% and will mature on April 1, 20...
Neutral
Business Wire
14 days ago
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of senior unsecured notes due 2033 (the “Notes”) in a private placement. The Company inten...
More Insulet Corporation News

Company Profile

Insulet Corp. is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Head office United States
CEO James Hollingshead
Employees 3,900
Founded 2000
Website www.insulet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today